Establishing secure connection…Loading editor…Preparing document…

Interdent Inc. Preliminary Proxy Statement Relating to Merger

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

VOTING AGREEMENT

Voting Agreement, dated as of (this "Agreement"), by and between , a Delaware corporation ("Recap"), and , an individual (the "Stockholder").

WHEREAS, , a Delaware corporation ("the Company"), and Recap are entering into an Agreement and Plan of Merger dated as of this date, as may be modified or amended from time to time in a manner not adverse to the Stockholder (the "Merger Agreement"), which provides, among other things, for the merger of Recap with and into the Company with the Company as the surviving corporation (the "Merger");

WHEREAS, in connection with the Merger Agreement, Recap has requested that the Stockholder make certain agreements with respect to certain shares of capital stock of the Company (the "Shares") beneficially owned by the Stockholder, upon the terms and subject to the conditions of this Agreement;

WHEREAS, in connection with the Merger Agreement, Recap and certain stockholders are entering into an Exchange and Subscription Agreement (the "Exchange Agreement"), which provides, among other things, for such stockholders to exchange their shares of capital stock of the Company for shares of capital stock of Recap prior to the Merger; and

WHEREAS, the Stockholder is willing to make certain agreements with respect to the Subject Shares (as defined below).

NOW, THEREFORE, in consideration of the promises and the mutual covenants and agreements set forth in this Agreement, the parties agree as follows:

1. VOTING AGREEMENTS. For so long as this Agreement is in effect, at any meeting of Stockholders of the Company, and in any action by consent of the Stockholders of the Company, the Stockholder shall vote, or, if applicable, give consents with respect to, all of the Subject Shares that are held by the Stockholder on the record date applicable to the meeting or consent (i) in favor of the Merger Agreement and the Merger contemplated by the Merger Agreement; (ii) against any competing Acquisition Proposal (as defined in the Merger Agreement) or other proposal inconsistent with the Merger Agreement or which may delay or adversely affect the likelihood of the completion of the Merger; (iii) against any change in a majority of the persons who constitute the board of directors of the Company inconsistent with the Merger Agreement or the Merger; (iv) against any change in the capitalization of the Company or any amendment of the Company's Certificate of Incorporation or Bylaws inconsistent with the Merger Agreement or the Merger; and (v) in favor of any other matter necessary for consummation of the transactions contemplated by the Merger Agreement which is considered at any such meeting or in any such consent. Such Stockholder shall not enter into any agreement or understanding with any person the effect of which would be inconsistent with or violate the provisions of agreements contained in this Section 1. The Stockholder shall use best efforts to cast the Stockholder's vote or give the Stockholder's consent in accordance with the procedures communicated to the Stockholder by the Company relating thereto so that the vote or consent shall be duly counted for purposes of determining that a quorum is present and for purposes of recording the results of that vote or consent.

2. SUBJECT SHARES. The term "Subject Shares" shall mean the Shares set forth on Schedule A hereto, together with any shares of capital stock of the Company acquired by the Stockholder after the date hereof over which the Stockholder has the power to vote or power to direct the voting.

3. COVENANTS. For so long as this Agreement is in effect, except as otherwise contemplated by the Merger Agreement or the Exchange Agreement, the Stockholder agrees not to (i) sell, transfer, pledge, assign, hypothecate, encumber, tender or otherwise dispose of, or enter into any contract with respect to the sale, transfer, pledge, assignment, hypothecation, encumbrance, tender or other disposition of (each such disposition or contract, a "Transfer"), any Subject Shares or Shares the Stockholder then has or will have the right to acquire pursuant to options, warrants, convertible securities or other such rights to purchase Shares granted to the Stockholder by the Company; (ii) grant any powers of attorney, consents, or proxies with respect to any shares that then constitute Subject Shares, deposit any of the Subject Shares into a voting trust, enter into a voting or option agreement with respect to any of the Subject Shares inconsistent with the Merger Agreement or this Agreement, or otherwise restrict or take any action adversely affecting the ability of the Stockholder freely to exercise all voting rights with respect to the Subject Shares; (iii) subject to Section 8, directly or indirectly, solicit, initiate, encourage or otherwise facilitate any inquiries or the making of any proposal or offer with respect to an Acquisition Proposal (as defined in the Merger Agreement) or engage in any negotiation concerning, or provide any confidential information or data to, or have any discussions with any person relating to an Acquisition Proposal; and the Stockholder shall notify Recap immediately if any such inquiries or proposals are received by, any such information is requested from, or any such negotiations or discussions are sought to be initiated or continued with the Stockholder; or (iv) permit, cause, or take any action, or fail to take any action, which would make any representation, warranty, covenant, or other undertaking of the Stockholder in this Agreement untrue or incorrect or prevent, burden or materially delay the consummation of the transactions contemplated by this Agreement; PROVIDED, HOWEVER, that nothing in the foregoing provisions of this Section 3 shall prohibit the Stockholder from effecting any transfer of Subject Shares pursuant to any bona fide charitable gift or by will or applicable laws of descent and distribution, or for estate planning purposes, if the transferee agrees in writing to be bound by the provisions of this Agreement. As used in this Agreement, "person" shall have the meaning specified in Sections 3(a)(9) and 13(d)(3) of the Securities Exchange Act of 1934, as amended.

4. WAIVER OF DISSENTERS' RIGHTS. The Stockholder hereby waives any rights to dissent from the Merger.

5. REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDER. The Stockholder represents and warrants to Recap that:

(a) CAPACITY; NO VIOLATIONS. The Stockholder has the legal capacity to enter into this Agreement and to consummate the transactions contemplated by this Agreement. This Agreement has been duly executed and delivered by the Stockholder and constitutes a valid and binding agreement of the Stockholder enforceable against the Stockholder in accordance with its terms except as such enforceability may be limited by applicable bankruptcy, insolvency and similar laws affecting creditors' rights generally and general principles of equity (whether considered in a proceeding in equity or at law). The execution, delivery and performance by the Stockholder of this Agreement will not (i) conflict with, require a consent, waiver or approval under, or result in a breach or default under, any of the terms of any contract, commitment or other obligation to which the Stockholder is a party or by which the Stockholder is bound, (ii) violate any order, writ, injunction, decree or statute, or any law, rule or regulation applicable to the Stockholder or the Subject Shares; or (iii) result in the creation of, or impose any obligation on the Stockholder to create, any Lien upon the Subject Shares that would prevent the Stockholder from voting the Subject Shares. In this Agreement, "Lien" shall mean any lien, pledge, security interest, claim, third party right or other encumbrance.

(b) SUBJECT SHARES. The Stockholder has the power to vote or direct the voting of the Subject Shares. The Subject Shares are the only shares of any class of capital stock of the Company which the Stockholder has the right, power or authority (sole or shared) to sell or vote, and, other than options, warrants or other convertible securities of the Company held by the Stockholder as of this date and set forth on Schedule B hereto, the Stockholder does not have any right to acquire, nor is it the beneficial owner of, any other shares of any class of capital stock of the Company or any securities convertible into or exchangeable or exercisable for any shares of any class of capital stock of the Company. The Stockholder is not a party to any contracts (including proxies, voting trusts or voting agreements) that would prevent the Stockholder from voting the Subject Shares or conflicts with the provisions of this Agreement.

(c) TITLE TO SHARES. Except as set forth on Schedule C, the Stockholder is the sole record and beneficial owner of the Subject Shares, free and clear of any pledge, lien, security interest, mortgage, charge, claim, equity, option, proxy, voting restriction, voting trust or agreement, understanding, arrangement, right of first refusal, limitation on disposition, adverse claim of ownership or use or encumbrance of any kind, other than restrictions imposed by the securities laws or pursuant to this Agreement or the Merger Agreement.

(d) NO FINDER'S FEES. Except as disclosed in the Merger Agreement, no broker, investment banker, financial advisor, or other person is entitled to any broker's, finder's, financial advisor's, or other similar fee or commission in connection with the transactions contemplated hereby based upon arrangements made by or on behalf of the Stockholder the payment of which could become the obligation of the Company or Recap. The Stockholder, on behalf of itself and its affiliates, hereby acknowledges that it is not entitled to receive any broker's, finder's, financial advisor's, or other similar fee or commission in connection with the transactions contemplated hereby or by the Merger Agreement.

6. EXPENSES. Each party to this Agreement shall pay its own expenses incurred in connection with this Agreement.

7. SPECIFIC PERFORMANCE. The Stockholder acknowledges and agrees that if Stockholder fails to perform any of Stockholder's obligations under this Agreement, immediate and irreparable harm or injury would be caused to Recap for which money damages would not be an adequate remedy. Accordingly, the Stockholder agrees that Recap shall have the right, in addition to any other rights it may have, to specific performance of this Agreement. If Recap should institute an action or proceeding seeking specific enforcement of the provisions of this Agreement, the Stockholder hereby waives the claim or defense that Recap has an adequate remedy at law and hereby agrees not to assert in that action or proceeding the claim or defense that a remedy at law exists. The Stockholder further agrees to waive any requirements for the securing or posting of any bond in connection with obtaining any equitable relief.

8. STOCKHOLDER CAPACITY. If the Stockholder is or becomes during the term hereof a director or officer of the Company, the Stockholder shall not be deemed to have made any agreement or understanding herein in his or her capacity as such director or officer. The Stockholder signs solely in Stockholder's capacity as the beneficial owner of the Stockholder's Subject Shares and nothing herein shall limit or affect any actions taken by the Stockholder in any capacity as an officer or director of the Company to the extent specifically permitted by the Merger Agreement. Nothing in this Agreement shall be deemed to constitute a transfer of the beneficial ownership of the Subject Shares by the Stockholder.

9. NOTICES. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed to have been duly given or made as of the date of receipt and shall be delivered personally or mailed by registered or certified mail (postage prepaid, return receipt requested), sent by overnight courier or sent by telecopy, to the applicable party at the following addresses or telecopy numbers (or at any other address or telecopy number for a party as shall be specified by like notice):

If to Recap, to:

Attention:

Telephone:

Facsimile:

With a copy to:

Attention:

Telephone:

Facsimile:

If to the Stockholder: at the address and telephone number set forth on the signature page.

With a copy to:

Attention:

Telephone:

Facsimile:

10. PARTIES IN INTEREST. This Agreement shall inure to the benefit of and be binding upon the parties and their respective successors and assigns; provided, however, that any successor in interest or assignee shall agree to be bound by the provisions of this Agreement. Nothing in this Agreement, express or implied, is intended to confer upon any Person other than Recap, the Stockholder or their successors or assigns, any rights or remedies under, or by reason, of this Agreement.

11. ENTIRE AGREEMENT; AMENDMENTS. Other than the Merger Agreement, the Exchange Agreement and the transactions contemplated therein, this Agreement contains the entire agreement between the Stockholder and Recap with respect to the subject matter of this Agreement and supersedes all prior and contemporaneous agreements and understandings, oral or written, with respect to these transactions. This Agreement may not be changed, amended or modified orally, but may be changed only by an agreement in writing signed by the party against whom any waiver, change, amendment, modification or discharge may be sought.

12. ASSIGNMENT. No party to this Agreement may assign any of its rights or obligations under this Agreement without the prior written consent of the other party to this Agreement, except that (a) Recap may assign its rights and obligations under this Agreement to GEI (as defined in the Merger Agreement) or any of GEI's or Recap's direct or indirect wholly owned subsidiaries or affiliates, and (b) the Stockholder may transfer the Subject Shares to the extent permitted by Section 3 of this Agreement.

13. HEADINGS. The section headings in this Agreement are for convenience only and shall not affect the construction of this Agreement.

14. COUNTERPARTS. This Agreement may be executed in any number of counterparts, each of which, when executed, shall be deemed to be an original and all of which together shall constitute one and the same document.

15. GOVERNING LAW. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without giving effect to any choice or conflict of law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware.

16. TERMINATION. This Agreement shall terminate automatically and without further action on behalf of any party at the earlier of (i) the Effective Time (as defined in the Merger Agreement) and (ii) the date the Merger Agreement is terminated pursuant to and in accordance with its terms.

In witness whereof, Recap and the Stockholder have caused this Agreement to be duly executed and delivered on the day and year first above written.

ID RECAP, INC.

By:

Title:

STEVEN R. MATZKIN

Signature:

Address:

Telephone Number:

Facsimile Number:

Enter text✕

What the Interdent Inc. Preliminary Proxy Statement Relating to Merger Is

The Interdent Inc. Preliminary Proxy Statement Relating to Merger is a formal disclosure document prepared by a public company to inform shareholders about the terms, rationale, and material effects of a proposed merger. It summarizes transaction structure, board recommendations, financial statements or pro forma information, risk factors, voting mechanics, and how the merger will affect corporate governance and shareholder rights. The preliminary proxy is typically filed with the U.S. Securities and Exchange Commission if the company is subject to SEC reporting requirements and distributed to shareholders for review prior to a shareholder vote.

Why the Preliminary Proxy Statement Matters

A clear, complete preliminary proxy gives shareholders the information they need to vote, reduces legal and regulatory risk, and documents the company’s disclosures. Accurate drafting supports SEC review and can limit challenges after the shareholder vote.

Why the Preliminary Proxy Statement Matters

Who Prepares and Reviews This Document

A cross-functional team usually prepares the preliminary proxy, combining legal, finance, investor relations, and corporate secretarial input.

  • Board of Directors and Corporate Secretary: Draft approval, attestations, and setting record and meeting dates.
  • Corporate Counsel and Securities Counsel: Legal review, SEC compliance, and disclosure counsel.
  • Finance and Accounting Teams: Prepare or review required financial statements and pro forma disclosures.

External advisors — corporate counsel, investment bankers, and proxy solicitors — typically review drafts and assist with distribution and compliance.

Primary Signatories and Decision Makers

Corporate Secretary

Typically certifies the proxy distribution and maintains records of filings, notices, and shareholder lists; coordinates signer routing and record retention for the proxy process.

Chief Legal Officer

Reviews disclosure language for accuracy and regulatory compliance, signs attestation sections when required, and oversees counsel for SEC responses and potential litigation risk mitigation.

Core Sections to Include in the Preliminary Proxy

A professional preliminary proxy statement organizes disclosure to help shareholders evaluate the merger and to comply with SEC and corporate law requirements.

Transaction Overview

Clear description of the merger structure, parties involved, consideration, and closing conditions so shareholders understand how ownership and control will change.

Board Recommendation

Formal statement from the board explaining why the merger is recommended, including any conflicts of interest and fairness considerations.

Financial Information

Required financial statements and pro forma calculations prepared or reviewed by finance teams and auditors to show the merger’s financial impact.

Risk Factors

Material risks specific to the transaction and post-merger company operations that could materially affect shareholder value or the ability to close.

Voting Procedures

Detailed instructions on record date, quorum, how to vote (in person, by proxy, electronically), and tabulation procedures for shareholder votes.

Solicitation and Fees

Disclosures about proxy solicitation methods, fees paid to advisors or solicitors, and any agreements with major shareholders or counterparties.

Stepwise Workflow to Prepare and Distribute the Preliminary Proxy

Follow a staged approach: draft, internal review, external review, file, distribute, and collect shareholder votes.

  • 01
    Draft Preparation: Compile transaction terms and financial exhibits for initial drafting.
  • 02
    Internal Review: Legal and finance review for accuracy and consistency.
  • 03
    SEC Filing: File required materials via EDGAR and resolve SEC staff comments.
  • 04
    Distribution: Send proxy materials to shareholders and track acknowledgements.

Digital Workflow Settings for eSubmission and Signing

Configure electronic routing, authentication, and retention before sending to ensure auditability and compliance.

Field Configuration
Authentication Method Email link with optional SMS code or KBA for higher assurance
Signature Order Sequential or parallel routing based on signer role
Audit Trail Enable IP, timestamp, and action logging for each signer
Integrations Connect to CRM or document management for recordkeeping

Digital Signing and File Format Considerations

Ensure your eSignature platform supports common filing formats and secure authentication for shareholder workflows.

  • File Formats: PDF, DOCX, and print-ready output
  • Integrations: Salesforce, NetSuite, Google Workspace, Box
  • Authentication: Email, SMS code, or advanced KBA

Typical eSignature Flow for Proxy Distribution

A standard online signing flow reduces manual handling while preserving an evidentiary audit trail for each signer.

  • Upload Document: Add the finalized proxy PDF to the signing platform
  • Place Fields: Insert signature, initial, and date fields where required
  • Send to Signers: Distribute via email or secure signing link
  • Collect Completion: Signed copies and a certificate of completion are generated

Typical Timing Considerations and Internal Deadlines

Plan backward from the intended shareholder meeting date; allow time for drafting, review cycles, SEC comments, printing, and distribution.

Draft Completion Window:

Finish initial draft 4–6 weeks before planned filing

Internal Review Time:

Allow 5–10 business days for cross-functional reviews

SEC Review Cycle:

Reserve time for comments and responsive amendments

Printing and Mail Lead Time:

Schedule physical mailings 10–30 days before meeting

Record Date Establishment:

Board sets record date to determine eligible voters

Key Milestones from Draft to Shareholder Vote

A sequential milestone list helps teams track required approvals and distribution steps leading to the shareholder meeting.

01

Board Approval

Board adopts the merger agreement and authorizes proxy materials.

02

Prepare Proxy

Legal and finance finalize disclosures and exhibits for filing.

03

File and Respond

File with SEC and address any staff comments promptly.

04

Distribute & Vote

Send materials to shareholders and collect votes before the meeting.

Electronic Signature vs Digital Signature: Key Differences

Understanding the distinction helps determine whether simple e-signatures suffice or cryptographic digital signatures are needed for regulatory purposes.

Criteria Electronic Signature Digital Signature
Legal Scope broad acceptance pki-based subset
Cryptography not required required
Non-repudiation audit trail evidence certificate-based non-repudiation
Regulatory Use esign/ueta valid required for some regulated workflows

eSignature Pricing Snapshot for Proxy Workflows

Compare vendor entry prices and basic feature availability for high-volume document distribution and compliance-sensitive workflows.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by plan Varies by plan Varies by plan Varies by plan
Bulk Send Yes Yes Yes Yes Varies by plan
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Common Mistakes to Avoid When Preparing a Merger Proxy

  • Incomplete financial exhibits or inconsistent pro forma calculations that trigger SEC comments or shareholder disputes.
  • Unclear voting instructions or incorrect record date disclosures that lead to invalid ballots or counting delays.
  • Missing or inconsistent board or advisor fee disclosures that create perceived conflicts of interest.
  • Failure to retain signed originals, certificates of completion, or audit trails undermining post-closing evidence.

Legal and Financial Risks of Errors or Omitted Disclosures

SEC Enforcement: Civil penalties and remediation orders
Shareholder Litigation: Injunctions, rescission claims, or damages
1099 Penalties: $60/$130/$330 per form depending on lateness
I-9 Violations: $281–$2,789 per violation
Intentional Disregard: $660+ per affected information return
Data Breach Exposure: HIPAA fines and regulatory penalties if PHI is mishandled

Illustrative Use Cases for Proxy Distribution and eSigning

These examples show how teams coordinate drafting, review, and e-distribution for a merger-related proxy in practice.

Use Case 1

A regional dental chain prepared a consolidated proxy package for a stock-for-stock merger with extensive pro forma exhibits

  • The company used staged internal approvals to finalize disclosures
  • By coordinating counsel, finance, and investor relations, the team resolved SEC comments within a single review cycle and distributed digital proxies to institutional and retail holders efficiently.

Use Case 2

A private equity-backed acquisition required rapid shareholder consent across multiple entities

  • Legal teams standardized signature blocks and assigned role-based signing order
  • Centralized retention of signed PDFs and an immutable audit trail simplified post-closing certification and internal recordkeeping.

Practical Tips for Accurate and Efficient Completion

Adopt consistent templates, version control, and a single source of truth for exhibits and numeric schedules to reduce errors.

Use a master checklist
Maintain a transaction checklist that tracks required disclosures, exhibits, approval dates, and responsible parties to avoid omissions during busy review cycles.
Standardize financial exhibits
Ensure pro forma adjustments are documented and reconciled to audited statements to prevent restatements or SEC inquiries.
Preserve audit trails
Retain signed PDFs and platform certificates showing signer identity, timestamps, IP addresses, and field-level events to support later verification.
Coordinate deadlines
Set internal blackout periods for edits and establish a single filer for EDGAR submissions to limit version confusion.

Frequently Asked Questions About the Preliminary Proxy and eSigning

Answers to common questions about filing, signatures, retention, and compliance for a merger-related preliminary proxy.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users